Synonym: (S)-(−)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
CAS Number: 100986-89-8
Empirical Formula (Hill Notation): C13H9F2NO4
Molecular Weight: 281.21
MDL Number: MFCD04039905
Linear Formula: C13H9F2NO4
Product Type: Chemical
API family |
levofloxacin |
application(s) |
pharmaceutical (small molecule) |
format |
neat |
grade |
pharmaceutical primary standard |
InChI |
1S/C13H9F2NO4/c1-5-4-20-12-9(15)8(14)2-6-10(12)16(5)3-7(11(6)17)13(18)19/h2-3,5H,4H2,1H3,(H,18,19)/t5-/m0/s1 |
InChI key |
NVKWWNNJFKZNJO-YFKPBYRVSA-N |
manufacturer/tradename |
USP |
mp |
>300 °C (lit.) |
optical activity |
[α]20/D -64°, c = 1% in DMSO |
SMILES string |
C[C@H]1COc2c(F)c(F)cc3C(=O)C(=CN1c23)C(O)=O |
Analysis Note: |
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: |
Levofloxacin Related Compound B USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. |
General description: |
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: |
Sales restrictions may apply. |
mp |
>300 °C (lit.) |
UNSPSC |
41116107 |